Heart failure in patients with human immunodeficiency virus infection: Epidemiology, pathophysiology, treatment, and future research

Circulation

Volumn 129, Issue 17, 2014, Pages 1781-1789

  Remick, Joshua ^a   Georgiopoulou, Vasiliki ^a   Marti, Catherine ^a   Ofotokun, Igho ^a   Kalogeropoulos, Andreas ^a   Lewis, William ^b   Butler, Javed ^a  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AIDS; cardiomyopathy; heart failure; HIV infection

Indexed keywords

ANTIRETROVIRUS AGENT;

CARDIAC RESYNCHRONIZATION THERAPY; CARDIOMYOPATHY; CORONARY ARTERY DISEASE; DEVICE THERAPY; DIASTOLIC DYSFUNCTION; HEART FAILURE; HEART MUSCLE INJURY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOTHERAPY; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SELENIUM DEFICIENCY; SYSTOLIC DYSFUNCTION;

AIDS; CARDIOMYOPATHY; HEART FAILURE; HIV INFECTION;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BIOMEDICAL RESEARCH; HEART FAILURE; HIV INFECTIONS; HIV-1; HUMANS; PREVALENCE;

EID: 84899739578     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.113.004574     Document Type: Review

References (98)

1. Mocroft A, Ledergerber B, Katlama C, Kirk O, Reiss P, d'Arminio Monforte A, Knysz B, Dietrich M, Phillips AN, Lundgren JD. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet. 2003;362:22-29. (Pubitemid 36835816)
2. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD; HIV Outpatient Study Investigators. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;338:853-860. (Pubitemid 28135961)
3. Ewings FM, Bhaskaran K, McLean K, Hawkins D, Fisher M, Fidler S, Gilson R, Nock D, Brettle R, Johnson M, Phillips A, Porter K. Survival following HIV infection of a cohort followed up from seroconversion in the UK. AIDS. 2008;22:89-95. (Pubitemid 350294882)
4. Ntsekhe M, Mayosi BM. Cardiac manifestations of HIV infection: an African perspective. Nat Clin Pract Cardiovasc Med. 2009;6:120-127.
5. Cohen IS, Anderson DW, Virmani R, Reen BM, Macher AM, Sennesh J, DiLorenzo P, Redfield RR. Congestive cardiomyopathy in association with the acquired immunodeficiency syndrome. N Engl J Med. 1986;315:628-630. (Pubitemid 16046978)
6. Levy WS, Simon GL, Rios JC, Ross AM. Prevalence of cardiac abnormalities in human immunodeficiency virus infection. Am J Cardiol. 1989;63:86-89. (Pubitemid 19018945)
7. De Castro S, Migliau G, Silvestri A, D'Amati G, Giannantoni P, Cartoni D, Kol A, Vullo V, Cirelli A. Heart involvement in AIDS: a prospective study during various stages of the disease. Eur Heart J. 1992;13:1452-1459.
8. Herskowitz A, Vlahov D, Willoughby S, Chaisson RE, Schulman SP, Neumann DA, Baughman KL. Prevalence and incidence of left ventricular dysfunction in patients with human immunodeficiency virus infection. Am J Cardiol. 1993;71:955-958. (Pubitemid 23118068)
9. De Castro S, d'Amati G, Gallo P, Cartoni D, Santopadre P, Vullo V, Cirelli A, Migliau G. Frequency of development of acute global left ventricular dysfunction in human immunodeficiency virus infection. J Am Coll Cardiol. 1994;24:1018-1024. (Pubitemid 24306413)
10. Akhras F, Dubrey S, Gazzard B, Noble MI. Emerging patterns of heart disease in HIV infected homosexual subjects with and without opportunistic infections: a prospective colour flow Doppler echocardiographic study. Eur Heart J. 1994;15:68-75. (Pubitemid 24081661)
11. Coudray N, de Zuttere D, Force G, Champetier de Ribes D, Pourny JC, Antony I, Lecarpentier Y, Chemla D. Left ventricular diastolic function in asymptomatic and symptomatic human immunodeficiency virus carriers: an echocardiographic study. Eur Heart J. 1995;16:61-67.
12. Barbaro G, Barbarini G, Di Lorenzo G; The Gruppo Italiano Per lo Studio Cardiologico dei Pazienti Affetti da AIDS. Early impairment of systolic and diastolic function in asymptomatic HIV-positive patients: a multicenter echocardiographic and echo-Doppler study. AIDS Res Hum Retroviruses. 1996;12:1559-1563. (Pubitemid 26366915)
13. Lipshultz SE, Easley KA, Orav EJ, Kaplan S, Starc TJ, Bricker JT, Lai WW, Moodie DS, McIntosh K, Schluchter MD, Colan SD; Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group. Left ventricular structure and function in children infected with human immunodeficiency virus: the prospective P2C2 HIV Multicenter Study. Circulation. 1998;97:1246-1256.
14. Pugliese A, Isnardi D, Saini A, Scarabelli T, Raddino R, Torre D. Impact of highly active antiretroviral therapy in HIV-positive patients with cardiac involvement. J Infect. 2000;40:282-284. (Pubitemid 30447185)
15. Bijl M, Dieleman JP, Simoons M, van der Ende ME. Low prevalence of cardiac abnormalities in an HIV-seropositive population on antiretroviral combination therapy. J Acquir Immune Defic Syndr. 2001;27:318-320. (Pubitemid 32661978)
16. Kristoffersen US, Lebech AM, Gerstoft J, Hesse B, Petersen CL, Gutte H, Kjaer A. Right and left cardiac function in HIV-infected patients investigated using radionuclide ventriculography and brain natriuretic peptide: a 5-year follow-up study. HIV Med. 2008;9:180-186. (Pubitemid 351279574)
17. Schuster I, Thöni GJ, Edérhy S, Walther G, Nottin S, Vinet A, Boccara F, Khireddine M, Girard PM, Mauboussin JM, Rouanet I, Dauzat M, Cohen A, Messner-Pellenc P, Obert P. Subclinical cardiac abnormalities in human immunodeficiency virus-infected men receiving antiretroviral therapy. Am J Cardiol. 2008;101:1213-1217.
18. Hsue PY, Hunt PW, Ho JE, Farah HH, Schnell A, Hoh R, Martin JN, Deeks SG, Bolger AF. Impact of HIV infection on diastolic function and left ventricular mass. Circ Heart Fail. 2010;3:132-139.
19. Reinsch N, Kahlert P, Esser S, Sundermeyer A, Neuhaus K, Brockmeyer N, Potthoff A, Erbel R, Buck T, Neumann T. Echocardiographic findings and abnormalities in HIV-infected patients: results from a large, prospective, multicenter HIV-heart study. Am J Cardiovasc Dis. 2011;1:176-184.
20. Mondy KE, Gottdiener J, Overton ET, Henry K, Bush T, Conley L, Hammer J, Carpenter CC, Kojic E, Patel P, Brooks JT. High prevalence of echocardiographic abnormalities among HIV-infected persons in the era of highly active antiretroviral therapy. Clin Infect Dis. 2011;52:378-386.
21. Blaylock JM, Byers DK, Gibbs BT, Nayak G, Ferguson M, Tribble DR, Porter C, Decker CF. Longitudinal assessment of cardiac diastolic function in HIV-infected patients. Int J STD AIDS. 2012;23:105-110.
22. Cerrato E, D'Ascenzo F, Biondi-Zoccai G, Calcagno A, Frea S, Grosso Marra W, Castagno D, Omedè P, Quadri G, Sciuto F, Presutti D, Frati G, Bonora S, Moretti C, Gaita F. Cardiac dysfunction in pauci symptomatic human immunodeficiency virus patients: a meta-analysis in the highly active antiretroviral therapy era. Eur Heart J. 2013;34:1432-1436.
23. Sliwa K, Carrington MJ, Becker A, Thienemann F, Ntsekhe M, Stewart S. Contribution of the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic to de novo presentations of heart disease in the Heart of Soweto Study cohort. Eur Heart J. 2012;33:866-874.
24. Sims A, Frank L, Cross R, Clauss S, Dimock D, Purdy J, Mikhail I, Hazra R, Hadigan C, Sable C. Abnormal cardiac strain in children and young adults with HIV acquired in early life. J Am Soc Echocardiogr. 2012;25:741-748.
25. Grandi AM, Nicolini E, Giola M, Gianni M, Maresca AM, Marchesi C, Guasti L, Balsamo ML, Venco A, Grossi PA. Left ventricular remodelling in asymptomatic HIV infection on chronic HAART: comparison between hypertensive and normotensive subjects with and without HIV infection. J Hum Hypertens. 2012;26:570-576.
26. Holloway CJ, Ntusi N, Suttie J, Mahmod M, Wainwright E, Clutton G, Hancock G, Beak P, Tajar A, Piechnik SK, Schneider JE, Angus B, Clarke K, Dorrell L, Neubauer S. Comprehensive cardiac magnetic resonance imaging and spectroscopy reveal a high burden of myocardial disease in HIV patients. Circulation. 2013;128:814-822.
27. Cardoso JS, Moura B, Martins L, Mota-Miranda A, Rocha Gonçalves F, Lecour H. Left ventricular dysfunction in human immunodeficiency virus (HIV)-infected patients. Int J Cardiol. 1998;63:37-45. (Pubitemid 28060224)
28. Currie PF, Jacob AJ, Foreman AR, Elton RA, Brettle RP, Boon NA. Heart muscle disease related to HIV infection: prognostic implications. BMJ. 1994;309:1605-1607.
29. Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL, Baughman KL, Kasper EK. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med. 2000;342:1077-1084. (Pubitemid 30207690)
30. Lipshultz SE, Easley KA, Orav EJ, Kaplan S, Starc TJ, Bricker JT, Lai WW, Moodie DS, Sopko G, Colan SD; Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group. Cardiac dysfunction and mortality in HIV-infected children: the Prospective P2C2 HIV Multicenter Study. Circulation. 2000;102:1542-1548.
31. Sackoff JE, Hanna DB, Pfeiffer MR, Torian LV. Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Ann Intern Med. 2006;145:397-406. (Pubitemid 46768570)
32. Crum NF, Riffenburgh RH, Wegner S, Agan BK, Tasker SA, Spooner KM, Armstrong AW, Fraser S, Wallace MR. Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. J Acquir Immune Defic Syndr. 2006;41:194-200.
33. Wever-Pinzon O, Bangalore S, Romero J, Silva Enciso J, Chaudhry FA. Inotropic contractile reserve can risk-stratify patients with HIV cardiomyopathy: a dobutamine stress echocardiography study. JACC Cardiovasc Imaging. 2011;4:1231-1238.
34. Tseng ZH, Secemsky EA, Dowdy D, Vittinghoff E, Moyers B, Wong JK, Havlir DV, Hsue PY. Sudden cardiac death in patients with human immunodeficiency virus infection. J Am Coll Cardiol. 2012;59:1891-1896.
35. Lewis W. Cardiomyopathy in AIDS: a pathophysiological perspective. Prog Cardiovasc Dis. 2000;43:151-170.
36. Lewis W. AIDS cardiomyopathy: physiological, molecular, and biochemical studies in the transgenic mouse. Ann N Y Acad Sci. 2001;946:46-56. (Pubitemid 33127208)
37. Welch K, Finkbeiner W, Alpers CE, Blumenfeld W, Davis RL, Smuckler EA, Beckstead JH. Autopsy findings in the acquired immune deficiency syndrome. JAMA. 1984;252:1152-1159. (Pubitemid 14067514)
38. Cammarosano C, Lewis W. Cardiac lesions in acquired immune deficiency syndrome (AIDS). J Am Coll Cardiol. 1985;5:703-706. (Pubitemid 15141980)
39. Reilly JM, Cunnion RE, Anderson DW, O'Leary TJ, Simmons JT, Lane HC, Fauci AS, Roberts WC, Virmani R, Parrillo JE. Frequency of myocarditis, left ventricular dysfunction and ventricular tachycardia in the acquired immune deficiency syndrome. Am J Cardiol. 1988;62(10 pt 1):789-793.
40. Lewis W. AIDS: cardiac findings from 115 autopsies. Prog Cardiovasc Dis. 1989;32:207-215. (Pubitemid 19274896)
41. Grody WW, Cheng L, Lewis W. Infection of the heart by the human immunodeficiency virus. Am J Cardiol. 1990;66:203-206. (Pubitemid 20235730)
42. Lipshultz SE, Fox CH, Perez-Atayde AR, Sanders SP, Colan SD, McIntosh K, Winter HS. Identification of human immunodeficiency virus-1 RNA and DNA in the heart of a child with cardiovascular abnormalities and congenital acquired immune deficiency syndrome. Am J Cardiol. 1990;66:246-250. (Pubitemid 20235744)
43. Shannon RP, Simon MA, Mathier MA, Geng YJ, Mankad S, Lackner AA. Dilated cardiomyopathy associated with simian AIDS in nonhuman primates. Circulation. 2000;101:185-193. (Pubitemid 30044259)
44. Wang YC, Neckelmann N, Mayne A, Herskowitz A, Srinivasan A, Sell KW, Ahmed-Ansari A. Establishment of a human fetal cardiac myocyte cell line. In Vitro Cell Dev Biol. 1991;27:63-74.
45. Barbaro G, Di Lorenzo G, Soldini M, Giancaspro G, Grisorio B, Pellicelli A, Barbarini G; Gruppo Italiano per lo Studio Cardiologico dei pazienti affetti da AIDS (GISCA). Intensity of myocardial expression of inducible nitric oxide synthase influences the clinical course of human immunodeficiency virus-associated cardiomyopathy. Circulation. 1999;100:933-939. (Pubitemid 29407173)
46. Kan H, Xie Z, Finkel MS. HIV gp120 enhances NO production by cardiac myocytes through p38 MAP kinase-mediated NF-kappaB activation. Am J Physiol. 2000;279:H3138-H3143. (Pubitemid 32005906)
47. Kan H, Xie Z, Finkel MS. p38 MAP kinase-mediated negative inotropic effect of HIV gp120 on cardiac myocytes. Am J Physiol. 2004;286:C1-C7. (Pubitemid 38055807)
48. Raidel SM, Haase C, Jansen NR, Russ RB, Sutliff RL, Velsor LW, Day BJ, Hoit BD, Samarel AM, Lewis W. Targeted myocardial transgenic expression of HIV Tat causes cardiomyopathy and mitochondrial damage. Am J Physiol. 2002;282:H1672-H1678. (Pubitemid 34654834)
49. Fang Q, Kan H, Lewis W, Chen F, Sharma P, Finkel MS. Dilated cardiomyopathy in transgenic mice expressing HIV Tat. Cardiovasc Toxicol. 2009;9:39-45.
50. Currie PF, Boon NA. Immunopathogenesis of HIV-related heart muscle disease: current perspectives. AIDS. 2003;17(suppl 1):S21-S28. (Pubitemid 36667777)
51. Currie PF, Goldman JH, Caforio AL, Jacob AJ, Baig MK, Brettle RP, Haven AJ, Boon NA, McKenna WJ. Cardiac autoimmunity in HIV related heart muscle disease. Heart. 1998;79:599-604. (Pubitemid 28289285)
52. Herskowitz A, Wu TC, Willoughby SB, Vlahov D, Ansari AA, Beschorner WE, Baughman KL. Myocarditis and cardiotropic viral infection associated with severe left ventricular dysfunction in late- stage infection with human immunodeficiency virus. J Am Coll Cardiol. 1994;24:1025-1032. (Pubitemid 24306414)
53. Yuan Y, Kan H, Fang Q, Chen F, Finkel MS. CXCR4 receptor antagonist blocks cardiac myocyte p38 MAP kinase phosphorylation by HIV gp120. Cardiovasc Toxicol. 2008;8:173-180.
54. Berzingi C, Chen F, Finkel MS. p38 MAP kinase inhibitor prevents diastolic dysfunction in rats following HIV gp120 injection in vivo. Cardiovasc Toxicol. 2009;9:142-150.
55. Hofmann U, Heuer S, Meder K, Boehler J, Lange V, Quaschning T, Ertl G, Bonz A. The proinflammatory cytokines TNF-alpha and IL-1 beta impair economy of contraction in human myocardium. Cytokine. 2007;39:157-162. (Pubitemid 47599971)
56. Monsuez JJ, Escaut L, Teicher E, Charniot JC, Vittecoq D. Cytokines in HIV-associated cardiomyopathy. Int J Cardiol. 2007;120:150-157. (Pubitemid 47049664)
57. Yearley JH, Mansfield KG, Carville AA, Sokos GG, Xia D, Pearson CB, Shannon RP. Antigenic stimulation in the simian model of HIV infection yields dilated cardiomyopathy through effects of TNFalpha. AIDS. 2008;22:585-594. (Pubitemid 351640591)
58. Pozzan G, Pagliari C, Tuon FF, Takakura CF, Kauffman MR, Duarte MI. Diffuse-regressive alterations and apoptosis of myocytes: possible causes of myocardial dysfunction in HIV-related cardiomyopathy. Int J Cardiol. 2009;132:90-95.
59. Chen F, Lewis W, Hollander JM, Baseler W, Finkel MS. N-Acetylcysteine reverses cardiac myocyte dysfunction in HIV-Tat proteinopathy. J Appl Physiol. 2012;113:105-113.
60. Brinkman K, ter Hofstede HJ, Burger DM, Smeitink JA, Koopmans PP. Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway. AIDS. 1998;12:1735-1744. (Pubitemid 28454438)
61. Lewis W, Copeland WC, Day B. Mitochondrial DNA depletion, oxidative stress and mutation: mechanisms of nucleoside reverse transcriptase inhibitor toxicity. Lab Invest. 2001;81:777-790. (Pubitemid 32553400)
62. Lewis W, Grupp IL, Grupp G, Hoit B, Morris R, Samarel AM, Bruggeman L, Klotman P. Cardiac dysfunction occurs in the HIV-1 transgenic mouse treated with zidovudine. Lab Invest. 2000;80:187-197. (Pubitemid 30120971)
63. McKenzie R, Fried MW, Sallie R, Conjeevaram H, Di Bisceglie AM, Park Y, Savarese B, Kleiner D, Tsokos M, Luciano C. Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B. N Engl J Med. 1995;333:1099-1105.
64. Comereski CR, Kelly WA, Davidson TJ, Warner WA, Hopper LD, Oleson FB. Acute cardiotoxicity of nucleoside analogs FddA and FddI in rats. Fundam Appl Toxicol. 1993;20:360-364. (Pubitemid 23138617)
65. Lipshultz SE, Easley KA, Orav EJ, Kaplan S, Starc TJ, Bricker JT, Lai WW, Moodie DS, Sopko G, Schluchter MD, Colan SD; Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection Study Group. Cardiovascular status of infants and children of women infected with HIV-1 (P(2)C(2) HIV): a cohort study. Lancet. 2002;360:368-373.
66. Lipshultz SE, Miller TL, Wilkinson JD, Scott GB, Somarriba G, Cochran TR, Fisher SD. Cardiac effects in perinatally HIV-infected and HIV- exposed but uninfected children and adolescents: a view from the United States of America. J Int AIDS Soc. 2013;16:18597.
67. Wilkinson JD, Williams PL, Leister E, Zeldow B, Shearer WT, Colan SD, Siberry GK, Dooley LB, Scott GB, Rich KC, Lipshultz SE, Pediatric HCS. Cardiac biomarkers in HIV-exposed uninfected children. AIDS. 2013;27:1099-1108.
68. Keshan Disease Research Group of the Chinese Academy of Medical Sciences. Observations on effect of sodium selenite in prevention of Keshan disease. Chin Med J (Engl). 1979;92:471-476.
69. Chariot P, Perchet H, Monnet I. Dilated cardiomyopathy in HIV-infected patients. N Engl J Med. 1999;340:732-735.
70. Boccara F, Lang S, Meuleman C, Ederhy S, Mary-Krause M, Costagliola D, Capeau J, Cohen A. HIV and coronary heart disease: time for a better understanding. J Am Coll Cardiol. 2013;61:511-523.
71. Lorgis L, Cottenet J, Molins G, Benzenine E, Zeller M, Aube H, Touzery C, Hamblin J, Gudjoncik A, Cottin Y, Quantin C. Outcomes after acute myocardial infarction in HIV-infected patients: analysis of data from a French nationwide hospital medical information database. Circulation. 2013;127:1767-1774.
72. Escaffre N, Morin M, Bouhnik AD, Fuzibet JG, Gastaut JA, Obadia Y, Moatti JP. Injecting drug users' adherence to HIV antiretroviral treatments: physicians' beliefs. AIDS Care. 2000;12:723-730. (Pubitemid 32059809)
73. Yehia BR, Fleishman JA, Wilson L, Hicks PL, Gborkorquellie TT, Gebo KA. Incidence of and risk factors for bacteraemia in HIV-infected adults in the era of highly active antiretroviral therapy. HIV Med. 2011;12:535-543.
74. Lipshultz SE, Orav EJ, Sanders SP, Colan SD. Immunoglobulins and left ventricular structure and function in pediatric HIV infection. Circulation. 1995;92:2220-2225.
75. Bozkurt B, Torre-Amione G, Warren MS, Whitmore J, Soran OZ, Feldman AM, Mann DL. Results of targeted anti-tumor necrosis factor therapy with etanercept (Enbrel) in patients with advanced heart failure. Circulation. 2001;103:1044-1047. (Pubitemid 32200174)
76. Rangasetty UC, Rahman AM, Hussain N. Reversible right ventricular dysfunction in patients with HIV infection. South Med J. 2006;99:274-278.
77. Diogenes MS, Carvalho AC, Succi RC. Reversible cardiomyopathy subsequent to perinatal infection with the human immunodeficiency virus. Cardiol Young. 2003;13:373-376. (Pubitemid 41630880)
78. Patel K, van Dyke RB, Mittleman MA, Colan SD, Oleske JM, Seage GR III. The impact of HAART on cardiomyopathy among children and adolescents perinatally infected with HIV-1. AIDS. 2012;26:2027-2037.
79. Lipshultz SE, Sleeper LA, Towbin JA, Lowe AM, Orav EJ, Cox GF, Lurie PR, McCoy KL, McDonald MA, Messere JE, Colan SD. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med. 2003;348:1647-1655. (Pubitemid 36459470)
80. Roland ME, Havlir DV. Responding to organ failure in HIV-infected patients. N Engl J Med. 2003;348:2279-2281. (Pubitemid 36638100)
81. Ciuffreda D, Pantaleo G, Pascual M. Effects of immunosuppressive drugs on HIV infection: implications for solid-organ transplantation. Transpl Int. 2007;20:649-658. (Pubitemid 47024913)
82. Anthuber M, Kemkes BM, Heiss MM, Schuetz A, Kugler C. HIV infection after heart transplantation: a case report. J Heart Lung Transplant. 1991;10:611-613.
83. Calabrese LH, Albrecht M, Young J, McCarthy P, Haug M, Jarcho J, Zackin R. Successful cardiac transplantation in an HIV-1-infected patient with advanced disease. N Engl J Med. 2003;348:2323-2328. (Pubitemid 36638106)
84. Gupta S, Markham DW, Mammen PP, Kaiser P, Patel P, Ring WS, Drazner MH. Long-term follow-up of a heart transplant recipient with documented seroconversion to HIV-positive status 1 year after transplant. Am J Transplant. 2008;8:893-896. (Pubitemid 351347762)
85. Uriel N, Jorde UP, Cotarlan V, Colombo PC, Farr M, Restaino SW, Lietz K, Naka Y, Deng MC, Mancini D. Heart transplantation in human immunodeficiency virus-positive patients. J Heart Lung Transplant. 2009;28:667-669.
86. Castel MA, Pérez-Villa F, Miro JM. Heart transplantation in HIV-infected patients: more cases in Europe. J Heart Lung Transplant. 2011;30:1418.
87. Fieno DS, Czer LS, Schwarz ER, Simsir S. Left ventricular assist device placement in a patient with end-stage heart failure and human immunodeficiency virus. Interact Cardiovasc Thorac Surg. 2009;9:919-920.
88. Mehmood S, Blais D, Martin S, Sai-Sudhakar C. Heartmate XVE destination therapy for end-stage heart failure in a patient with human immunodeficiency virus. Interact Cardiovasc Thorac Surg. 2009;9:909-910.
89. Sims DB, Uriel N, González-Costello J, Deng MC, Restaino SW, Farr MA, Takayama H, Mancini DM, Naka Y, Jorde UP. Human immunodeficiency virus infection and left ventricular assist devices: a case series. J Heart Lung Transplant. 2011;30:1060-1064.
90. Joyce DL, Southard RE, Torre-Amione G, Noon GP, Land GA, Loebe M. Impact of left ventricular assist device (LVAD)-mediated humoral sensitization on post-transplant outcomes. J Heart Lung Transplant. 2005;24:2054-2059. (Pubitemid 41814724)
91. Li D, Wu Q, Sun L, Song Y, Wang W, Pan S, Luo G, Liu Y, Qi Z, Tao T, Sun JZ, Hu S. Surgical treatment of giant coronary artery aneurysm. J Thorac Cardiovasc Surg. 2005;130:817-821. (Pubitemid 41265725)
92. Popma JJ, Tiroch K, Almonacid A, Cohen S, Kandzari DE, Leon MB. A qualitative and quantitative angiographic analysis of stent fracture late following sirolimus-eluting stent implantation. Am J Cardiol. 2009;103:923-929.
93. Klein J, Hakimian J, Makaryus AN. Spontaneous right coronary artery dissection: causing myocardial infarction in a 36-year-old woman. Tex Heart Inst J. 2012;39:95-98.
94. Ho NC, Tran JR, Bektas A. Marfan's syndrome. Lancet. 2005; 366:1978-1981. (Pubitemid 41713990)
95. Cooper LT Jr, Berry GJ, Shabetai R. Idiopathic giant-cell myocarditis- natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators. N Engl J Med. 1997;336:1860-1866. (Pubitemid 27263973)
96. Korosoglou G, Youssef AA, Bilchick KC, Ibrahim el-S, Lardo AC, Lai S, Osman NF. Real-time fast strain-encoded magnetic resonance imaging to evaluate regional myocardial function at 3.0 Tesla: comparison to conventional tagging. J Magn Reson Imaging. 2008;27:1012-1018. (Pubitemid 351614611)
97. Mewton N, Liu CY, Croisille P, Bluemke D, Lima JA. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardiol. 2011;57:891-903.
98. Geyer H, Caracciolo G, Abe H, Wilansky S, Carerj S, Gentile F, Nesser HJ, Khandheria B, Narula J, Sengupta PP. Assessment of myocardial mechanics using speckle tracking echocardiography: fundamentals and clinical applications. J Am Soc Echocardiogr. 2010;23:351-369; quiz 453.